These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
18. Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia. Sacchi S; Kantarjian HM; Freireich EJ; O'Brien S; Cortes J; Rios MB; Kornblau S; Giles FJ; Koller C; Gajewski J; Talpaz M Leuk Lymphoma; 1999 Nov; 35(5-6):483-9. PubMed ID: 10609785 [TBL] [Abstract][Full Text] [Related]
19. High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia. Hiddemann W; Kreutzmann H; Straif K; Ludwig WD; Mertelsmann R; Planker M; Donhuijsen-Ant R; Lengfelder E; Arlin Z; Büchner T Semin Oncol; 1987 Jun; 14(2 Suppl 1):73-7. PubMed ID: 3473685 [TBL] [Abstract][Full Text] [Related]
20. Fludarabine and cytarabine versus high-dose cytarabine in consolidation treatment of t(8; 21) acute myeloid leukemia: A prospective, randomized study. Li R; Hu X; Wang L; Cheng H; Lv S; Zhang W; Wang J; Yang J; Song X Am J Hematol; 2017 Jan; 92(1):12-17. PubMed ID: 27673579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]